DIPROMON

The DIPROMON platform will allow design of a novel patient stratification concept, building the tools, technologies and procedures to apply this concept to the bladder cancer patient scenario. The final stage will be validating the concept in patients with bladder cancer.

The role of LIONEX in Dirpomon is to discover, characterise and produce purified biomarkers for test development.